News Industry News HeartStitch® Brings New Technology to Astana to Treat Structural Heart Disease September 11, 2015
News Daily News Short-term Readmission Rates Similar After TAVR vs SAVR Todd Neale September 10, 2015
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Daily News COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization L.A. McKeown September 09, 2015
News Daily News Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización L.A. McKeown September 09, 2015
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
Presentation Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease Presenter: S.K. Padala September 08, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care L.A. McKeown September 02, 2015
News Conference News ESC 2015 Registry Provides Support for Use of MitraClip in Lower-Risk Patients L.A. McKeown September 01, 2015
News Conference News ESC 2015 NSAIDs Plus Anticoagulants a Bad Combination Caitlin E. Cox September 01, 2015
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Conference News ESC 2015 TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics Yael L. Maxwell August 31, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015
News Conference News ESC 2015 FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP Yael L. Maxwell August 30, 2015